Q95460 (HMR1_HUMAN) Homo sapiens (Human)

Major histocompatibility complex class I-related gene protein UniProtKBInterProSTRINGInteractive Modelling

341 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5)

Available Structures

61 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of human MAIT A-F7 TCR in complex with human MR1-5'OH-Pentyl-5-OP-U Heteromer
P61769;
23-292
OYD;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-2`OH-Ethyl-5-OP-U Heteromer
P61769;
23-292
GOL;OZD;NA;
Assess
Structure of E8 TCR in complex in human MR1 bound to 5FSA Heteromer
P61769;
23-292
54G;EDO;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1 3'D-5-OP-RU Heteromer
P61769;
23-292
GOL;Q81;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-5-OP-RU Heteromer
P61769;
23-292
Q87;GOL;CL;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-Ribityl-less Heteromer
P61769;
23-292
OYG;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H-Ac-6-FP Heteromer
P61769;
23-292
TKG;GOL;CL;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-4'D-5-OP-RU Heteromer
P61769;
23-292
GOL;Q7J;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-5'D-5-OP-RU Heteromer
P61769;
23-292
2LJ;GOL;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-3`OH-Propyl-5-OP-U Heteromer
P61769;
23-292
GOL;CL;Q7S;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H without ligand Heteromer
P61769;
23-292
ACT;GOL;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-DB28 Heteromer
P61769;
23-292
GOL;P1J;ACT;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-2'D-5-OP-RU Heteromer
P61769;
23-292
GOL;Q84;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-4'OH-Butyl-5-OP-U Heteromer
P61769;
23-292
Q7P;GOL;NA;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT TRAJ20 TCR Heteromer
P61769;
23-292
2LJ;GOL;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-JYM72 Heteromer
P61769;
23-292
GOL;OYV;NA;
Assess
Structure of human MAIT A-F7 TCR in complex with human MR1-NV18.1 Heteromer
P61769;
23-292
N18;GOL;ACT;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT M33.64 TCR Heteromer
P61769;
23-292
2LJ;
Assess
Structure of E8 TCR in complex in human MR1 K43A Heteromer
P61769;
23-292
Assess
Structure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OH Heteromer
P01850; P61769; Q6P4G7;
23-291
1VY;GOL;
Assess
Structure of human MR1-3-F-SA in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
7ZS;GOL;ACT;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT B-B10 TCR Heteromer
P61769;
23-291
CL;GOL;ACT;30W;NA;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT M33.64(Y95alphaF) TCR Heteromer
P61769;
23-291
GOL;2LJ;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT B-G8 TCR Heteromer
P61769;
23-291
GOL;30W;NA;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT M33.64 TCR Heteromer
P61769;
23-291
PRO;30W;GOL;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT TRBV6-1 TCR Heteromer
P61769;
23-291
30W;
Assess
Structure of human MAIT TCR in complex with human MR1-6-FP Heteromer
P01850; P61769;
23-291
6FP;
Assess
Structure of human MR1-2-OH-1-NA in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
7WO;GOL;CL;NA;
Assess
Structure of E8 TCR in complex in human MR1 bound to 3FSA Heteromer
P61769;
23-291
7ZS;
Assess
Crystal structure of TCR-MR1 ternary complex bound to 5-(2-oxoethylideneamino)-6-D-ribitylaminourac… Heteromer
P01850; P61769; Q6P4G7;
23-291
2L4;
Assess
Structure of E8 TCR in complex in human MR1 bound to 4FBA Heteromer
P61769;
23-291
4MA;EDO;
Assess
Structure of human MR1-DA-6-FP in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
7WP;GOL;NA;
Assess
Structure of human MR1-HMB in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
PRO;7WQ;GOL;
Assess
Crystal structure of TCR-MR1 ternary complex and non-covalently bound 5-(2-oxopropylideneamino)-6-D… Heteromer
P01850; P61769; Q6P4G7;
23-291
2LJ;GOL;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT C-A11 TCR Heteromer
P61769;
23-291
30W;CL;GOL;B3P;
Assess
Structure of E8 TCR in complex in human MR1 bound to 3FBA Heteromer
P61769;
23-291
OVV;EDO;MPO;
Assess
The structure of human MAIT TCR in complex with MR1-K43A-RL-6-Me-7OH Heteromer
P01850; P61769; Q6P4G7;
23-291
GOL;1VY;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT B-F3-C1 TCR Heteromer
P61769;
23-291
30W;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT B-C10 TCR Heteromer
P61769;
23-291
30W;GOL;
Assess
Structure of human MR1-Ac-6-FP in complex with human MAIT C-C10 TCR Heteromer
P61769;
23-291
30W;GOL;NA;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT TRBV6-4 TCR Heteromer
P61769;
23-291
2LJ;
Assess
Crystal structure of TCR-MR1 ternary complex and covalently bound 5-(2-oxopropylideneamino)-6-D-rib… Heteromer
P01850; P61769; Q6P4G7;
23-291
2LJ;NA;
Assess
Structure of human MR1-ethylvanillin in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
PRO;N36;GOL;
Assess
Structure of human MR1-5OH-DCF in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
ACT;GOL;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT C-A11 TCR Heteromer
P61769;
23-291
2LJ;B3P;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT B-B10 TCR Heteromer
P61769;
23-291
2LJ;GOL;
Assess
Structure of human MR1-diclofenac in complex with human MAIT A-F7 TCR Heteromer
P61769;
23-291
NA;ACT;GOL;DIF;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT C-C10 TCR Heteromer
P61769;
23-291
2LJ;GOL;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT B-F3-C1 TCR Heteromer
P61769;
23-291
2LJ;GOL;
Assess
Structure of human D462-E4 TCR in complex with human MR1-5-OP-RU Heteromer
P61769;
23-291
2LJ;GOL;BR;NA;CL;
Assess
Inhibitory immune receptor protein complex Heteromer
P61769;
23-291
30W;
Assess
Structure of MHC-class I related molecule MR1 Heteromer
P61769;
24-292
6FP;CL;PO4;
Assess
Stimulatory immune receptor protein complex Heteromer
A0A0C4DH27; A0JD37; P61769;
23-291
2LJ;
Assess
Recognition of MHC-like molecule Heteromer
P61769;
24-292
2LJ;NAG;
Assess
Structure of human MR1-5-OP-RU in complex with human MAIT TRBV20 TCR Heteromer
P61769;
23-291
2LJ;NA;
Assess
Structure of human MR1-5-OP-RU in complex with human MAV36 TCR Heteromer
P61769;
23-291
2LJ;
Assess
Structure of E8 TCR in complex with human MR1 bound to 6FP Heteromer
P61769;
23-290
JSO;
Assess
Structure of E8 TCR in complex with human MR1 bound to 5-OP-RU Heteromer
P61769;
23-290
2LJ;EDO;
Assess
Crystal structure of human CD8aa-MR1-Ac-6-FP complex Heteromer
P01732; P61769;
23-287
30W;PO4;CL;
Assess
Model of the Ac-6-FP/hpMR1/bB2m/TAPBPR complex from integrated docking, NMR and restrained MD Heteromer
C1ITJ8; P01888; Q9BX59;
34-204
30W;
Assess
Structure of MHC-class I related molecule MR1 with bound M3Ademonomer23-291
R8F;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8bp6.1.Amonomer0.8522-291
98.90
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28bp6.1.Amonomer0.8122-246
97.80
Assess
Isoform 38bp6.1.Amonomer0.7822-248
82.97
Assess
Isoform 48bp6.1.Amonomer0.8722-219
91.00
Assess
Isoform 58bp6.1.Amonomer0.8722-212
93.26
Assess